Author

Josep M. Argimón

Observed names: J Argimon, J Argimón, J M Argimon, J M Argimón, J. Argimon, J. Argimón, J. M Argimon, J. M. Argimon, J.M. Argimon, Josep Argimon, Josep M Argimon, Josep M. Argimon, Josep Ma. Argimón, Josep Maria Argimon, Josep Maria Argimón, Josep María Argimón, Josep-Maria Argimon, Josep M. Argimon

Institutions: Generalitat de Catalunya, Departament de Salut

Observed institutions: Universitat Autònoma de Barcelona, Generalitat de Catalunya, Bellvitge University Hospital, Departament de Salut, Agència de Qualitat i Avaluació Sanitàries de Catalunya, Institut Català de la Salut, Hospital Universitari Germans Trias i Pujol, Fundació Lluita contra les Infeccions, Universitat de Barcelona

OpenAlex ID: A5111909429

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial

2020 · Oriol Mitjà, Marc Corbacho-Monné, et al. · Clinical Infectious Diseases · 290

PDF

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19

2020 · Oriol Mitjà, Marc Corbacho-Monné, et al. · New England Journal of Medicine · 264

Evidence based practice in postgraduate healthcare education: A systematic review

2007 · Gemma Flores-Mateo, Josep M Argimon · BMC Health Services Research · 178

PDF

The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries – Study Design and Baseline Findings

2013 · Anders Wimo, Catherine C. Reed, et al. · Journal of Alzheimer s Disease · 162

PDF

Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study

2014 · Catherine Reed, Mark Belger, et al. · Dementia and Geriatric Cognitive Disorders Extra · 123

PDF

Effectiveness of Organizational Interventions to Reduce Emergency Department Utilization: A Systematic Review

2012 · Gemma Flores-Mateo, Concepción Violan-Fors, et al. · PLoS ONE · 123

PDF

Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours

2014 · J.M. Haro, Kristin Kahle-Wrobleski, et al. · The journal of nutrition health & aging · 111

Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study

2011 · J Prades, J A Espinàs, et al. · British Journal of Cancer · 88

PDF

2004 · J. M Argimon · Family Practice · 84

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study

2021 · Carmen Cabezas, Ermengol Coma, et al. · BMJ · 81

PDF

2005 · Josep M Argimon, Esther Limon, et al. · Alzheimer Disease & Associated Disorders · 79

Determinants of societal costs in Alzheimer's disease: GERAS study baseline results

2015 · Richard Dodel, Mark Belger, et al. · Alzheimer s & Dementia · 77

Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer’s disease dementia

2018 · Mark Belger, Josep Maria Haro, et al. · The European Journal of Health Economics · 54

PDF

How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer’s disease?

2017 · Catherine Reed, Annabel Barrett, et al. · Health and Quality of Life Outcomes · 54

PDF

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes

2017 · Roy W. Jones, Jeremie Lebrec, et al. · Dementia and Geriatric Cognitive Disorders Extra · 51

PDF

Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma

1995 · Miquel Ribera, Xavier Pintó, et al. · The American Journal of Medicine · 50

Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease

2015 · Catherine Reed, Mark Belger, et al. · International Psychogeriatrics · 47

Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study

2017 · Javier Olazarán, Luis Agüera-Ortiz, et al. · International Psychogeriatrics · 45

Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis

2000 · Albert Salazar, Juan Maña, et al. · Atherosclerosis · 45

The development and successful implementation of the VINCat Program

2012 · Francesc Gudiol, Enric Limón, et al. · Enfermedades Infecciosas y Microbiología Clínica · 40

Frequency of health-care service use and severity of illness in undocumented migrants in Catalonia, Spain: a population-based, cross-sectional study

2021 · Albert Dalmau-Bueno, Anna García-Altés, et al. · The Lancet Planetary Health · 38

PDF

Narrowing the Equity Gap: The Impact of Organized versus Opportunistic Cancer Screening in Catalonia (Spain)

2011 · Josep A Espinas, Luisa Aliste, et al. · Journal of Medical Screening · 38

PDF

Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia

2002 · Albert Salazar, Juan Mañá, et al. · Clinica Chimica Acta · 33

Evolving Mortality and Clinical Outcomes of Hospitalized Subjects During Successive COVID-19 Waves in Catalonia, Spain

2021 · Albert Roso-Llorach, Xavier Serra-Picamal, et al. · Global Epidemiology · 29

What Drives Country Differences in Cost of Alzheimer’s Disease? An Explanation from Resource Use in the GERAS Study

2017 · Catherine Reed, Michael Happich, et al. · Journal of Alzheimer s Disease · 29

PDF

Works count: 71

Citation count: 2,530

H-index: 27

I10-index: 41